Our findings indicate that IL-1R2 could bridge the causal link between intestinal microorganisms and hypertension, laying the groundwork for exploring the intersection of hypertension and inflammation and potentially inspiring future therapeutic strategies for hypertension. This evidence concerns the gene IL1R2 and hypertensive disorder.